Business
Bell’s Palsy Symptoms Relieved By Full-Spectrum CBD Oil
Bell’s Palsy is a condition where the facial nerve is inflamed, compressed or otherwise swollen. The muscles in the face either droop or go into painful paralysis. For Curt Platt, half of his face suddenly droopped one day a couple weeks after going through a virus such as he’d never before experienced. Now it seems Bell’s palsy symptoms relieved by full-spectrum CBD oil.
Platt stood urinating into the toilet, and as is his morning habit, he went to spit into the receptacle while relieving himself. Only the spit didn’t clear his chest, not once, not twice but several times. He looked up into the mirror and couldn’t believe his eyes, the left one of which was unable to blink. Platt went to the doctor immediately who in turn diagnosed him within minutes.
That diagnosis was 12 years ago and in that time, though the initial symptoms cleared after a matter of weeks, Platt has experienced recurrences of Bell’s palsy that put him out of commision for sometimes weeks at a time. These relapses happened around once a year, sometimes skipping a year, sometimes doubling up, but were usually stress related, at least in Platt’s opinion.
During that time, the man who had spent decades on Wall Street tried everything he could to mitigate the Bell’s palsy symptoms. He visited doctors Florida, tried different specialists, was recommended muscle relaxers to which he said, “No thank you,” did his own research and nothing worked, that is until a buddy turned him onto full spectrum CBD tincture.
Platt was skeptical while waiting for the oil to come in the mail, but, “I was still watching for it,” laughed Platt, who told The Fresh Toast that by that time he was desperate to try anything that came recommended. He also added that, “Doctors don’t have a clue.” Someone he has grown to have faith in, however, is Andrew Clark, cofounder of World Class Health CBD. Clark was the one to recommend a CBD tincture also rich in the cannabinoid CBG.
When said tincture arrived at Platt’s location, he was in the throes of a full on episode. He didn’t feel well and didn’t have control over the left side of his face. “How long should I wait before expecting results?” was one of Platt’s first questions and he balked at the assertion that he should see something within minutes.
Lo and behold, some five to 10 minutes later his friend who he was staying with in Florida came home and said, “Hey, your face looks better!” and Platt retorted that he felt better as well. He kept taking the tincture at the high dose until the symptoms receded 100 percent (they had already gone down 90 percent in that 10 minute span). Now he takes a maintenance dose and hasn’t had a relapse since April of this year.
TFT: Is there any detectable THC in your medicines?
AC: It’s completely THC free. It’s all the way undetectable. We start out with hemp plants with less than .3 percent THC. We extract the oil and it still has some THC in it, so what we do is use chromatography to remove the THC, so we go the extra step… A lot of people in the industry dilute their tincture or oil with the solute they’re using, so that way they get the less than .3 percent to make it legal, but they’ve diluted the CBD content, so then they pour isolate in to increase the CBD. The thing that’s unfortunate is when they put the isolate back in, they’re not putting the CBN, the CBC, the CBG, so you’re getting extremely low on the other cannabinoids when you choose to dilute rather than use chromatography. Even though it’s a little more expensive it’s a much better product.
TFT: The tincture you send Curt is high in CBG, why?
AC: Unfortunately there’s not enough research being done because [every part of cannabis] is Schedule I, but I have read certain studies that have come out of Israel that CBG has really good effects on your nerves and can even be shown to cause neurogenesis, which is the regrowing of brain tissue basically. So with Bell’s palsy, his facial nerve, what’s going on there is it gets swollen and then the myelin sheath around the nerve begins to clamp down on that nerve, so the nerve begins to lose function and if it stays clamped too long, that’s when the nerve can die. That’s where we see the long term Bell’s palsy. So I thought with the anti-inflammatory properties of CBD and the small amount I’ve read about CBG causing neurogenesis – some people are even calling it the stem cell cannabinoid – the combination of the two would be the best chance we would have to treat him.
TFT: Is there an entourage effect with the different cannabinoids Curt is using?
AC: Certain cannabinoids are better for certain jobs than others, so, sometimes it takes the anti-inflammatory of CBD to bring down that myelin sheath around his facial nerve and then the CBG to do its magic on reviving that nerve, so there’s definitely a synergistic effect, and you’ll see that with CBN as well. CBN really helps people with sleep as well as with osteoporosis. There’s absolutely a synergistic effect and that’s why our tinctures are full spectrum.
TFT: What about THC, where is its place at the table medicinally in your opinion?
AC: THC gets kind of a bad rap because it gives you that stoned effect that can be dangerous if people get behind the wheel or certain things, but it can be used synergistically with CBD or for the treatment of certain diseases, for example Parkinson’s has a great reaction to THC. There’s actually a video on our website of a gentlemen who takes I believe a 1:1 ratio of THC to CBD and it takes away his shakes and brings back his voice within five minutes. So I definitely think there’s a place for THC in the medicinal world, but it’s going to be a while before we can get some more studies done and everything is cleared off Schedule I. Fingers are crossed data will indicate Bell’s palsy symptoms relieved by full-spectrum CBD oil.
Source: https://thefreshtoast.com/cannabis/bells-palsy-symptoms-relieved-by-full-spectrum-cbd-oil/
New Mexico regulators fined a cannabis operator nearly $300,000 and revoked its license after the company allegedly created fake reports in the state’s traceability software.
The New Mexico Cannabis Control Division (CCD) accused marijuana manufacturer and retailer Golden Roots of 11 violations, according to Albuquerque Business First.
Golden Roots operates the The Cannabis Revolution Dispensary.
The majority of the violations are related to the Albuquerque company’s improper use of BioTrack, which has been New Mexico’s track-and-trace vendor since 2015.
The CCD alleges Golden Roots reported marijuana production only two months after it had received its vertically integrated license, according to Albuquerque Business First.
Because cannabis takes longer than two months to be cultivated, the CCD was suspicious of the report.
After inspecting the company’s premises, the CCD alleged Golden Roots reported cultivation, transportation and sales in BioTrack but wasn’t able to provide officers who inspected the site evidence that the operator was cultivating cannabis.
In April, the CCD revoked Golden Roots’ license and issued a $10,000 fine, according to the news outlet.
The company requested a hearing, which the regulator scheduled for Sept. 1.
At the hearing, the CCD testified that the company’s dried-cannabis weights in BioTrack were suspicious because they didn’t seem to accurately reflect how much weight marijuana loses as it dries.
Company employees also poorly accounted for why they were making adjustments in the system of up to 24 pounds of cannabis, making comments such as “bad” or “mistake” in the software, Albuquerque Business First reported.
Golden Roots was fined $298,972.05 – the amount regulators allege the company made selling products that weren’t properly accounted for in BioTrack.
The CCD has been cracking down on cannabis operators accused of selling products procured from out-of-state or not grown legally:
- Regulators alleged in August that Albuquerque dispensary Sawmill Sweet Leaf sold out-of-state products and didn’t have a license for extraction.
- Paradise Exotics Distro lost its license in July after regulators alleged the company sold products made in California.
Golden Roots was the first alleged rulebreaker in New Mexico to be asked to pay a large fine.
Source: https://mjbizdaily.com/new-mexico-cannabis-operator-fined-loses-license-for-alleged-biotrack-fraud/
Four marijuana companies, including a multistate operator, have filed a lawsuit against U.S. Attorney General Merrick Garland in which they allege the federal MJ prohibition under the Controlled Substances Act is no longer constitutional.
According to the complaint, filed Thursday in U.S. District Court in Massachusetts, retailer Canna Provisions, Treevit delivery service CEO Gyasi Sellers, cultivator Wiseacre Farm and MSO Verano Holdings Corp. are all harmed by “the federal government’s unconstitutional ban on cultivating, manufacturing, distributing, or possessing intrastate marijuana.”
Verano is headquartered in Chicago but has operations in Massachusetts; the other three operators are based in Massachusetts.
The lawsuit seeks a ruling that the “Controlled Substances Act is unconstitutional as applied to the intrastate cultivation, manufacture, possession, and distribution of marijuana pursuant to state law.”
The companies want the case to go before the U.S. Supreme Court.
They hired prominent law firm Boies Schiller Flexner to represent them.
The New York-based firm’s principal is David Boies, whose former clients include Microsoft, former presidential candidate Al Gore and Elizabeth Holmes’ disgraced startup Theranos.
Similar challenges to the federal Controlled Substances Act (CSA) have failed.
One such challenge led to a landmark Supreme Court decision in 2005.
In Gonzalez vs. Raich, the highest court in the United States ruled in a 6-3 decision that the commerce clause of the U.S. Constitution gave Congress the power to outlaw marijuana federally, even though state laws allow the cultivation and sale of cannabis.
In the 18 years since that ruling, 23 states and the District of Columbia have legalized adult-use marijuana and the federal government has allowed a multibillion-dollar cannabis industry to thrive.
Since both Congress and the U.S. Department of Justice, currently headed by Garland, have declined to intervene in state-licensed marijuana markets, the key facts that led to the Supreme Court’s 2005 ruling “no longer apply,” Boies said in a statement Thursday.
“The Supreme Court has since made clear that the federal government lacks the authority to regulate purely intrastate commerce,” Boies said.
“Moreover, the facts on which those precedents are based are no longer true.”
Verano President Darren Weiss said in a statement the company is “prepared to bring this case all the way to the Supreme Court in order to align federal law with how Congress has acted for years.”
While the Biden administration’s push to reschedule marijuana would help solve marijuana operators’ federal tax woes, neither rescheduling nor modest Congressional reforms such as the SAFER Banking Act “solve the fundamental issue,” Weiss added.
“The application of the CSA to lawful state-run cannabis business is an unconstitutional overreach on state sovereignty that has led to decades of harm, failed businesses, lost jobs, and unsafe working conditions.”
Alabama regulators are targeting Dec. 1 to award the first batch of medical cannabis business licenses after the agency’s first two attempts were scrapped because of scoring errors and litigation.
The first licenses will be awarded to individual cultivators, delivery providers, processors, dispensaries and state testing labs, according to the Alabama Medical Cannabis Commission (AMCC).
Then, on Dec. 12, the AMCC will award licenses for vertically integrated operations, a designation set primarily for multistate operators.
Licenses are expected to be handed out 28 days after they have been awarded, so MMJ production could begin in early January, according to the Alabama Daily News.
That means MMJ products could be available for patients around early March, an AMCC spokesperson told the media outlet.
Regulators initially awarded 21 business licenses in June, only to void them after applicants alleged inconsistencies with how the applications were scored.
Then, in August, the state awarded 24 different licenses – 19 went to June recipients – only to reverse themselves again and scratch those licenses after spurned applicants filed lawsuits.
A state judge dismissed a lawsuit filed by Chicago-based MSO Verano Holdings Corp., but another lawsuit is pending.
Source: https://mjbizdaily.com/alabama-plans-to-award-medical-cannabis-licenses-dec-1/
New Mexico cannabis operator fined, loses license for alleged BioTrack fraud
Marijuana companies suing US attorney general in federal prohibition challenge
Alabama to make another attempt Dec. 1 to award medical cannabis licenses
Pot Odor Does Not Justify Probable Cause for Vehicle Searches, Minnesota Court Affirms
New Mexico cannabis operator fined, loses license for alleged BioTrack fraud
Alabama to make another attempt Dec. 1 to award medical cannabis licenses
-
Business1 year agoPot Odor Does Not Justify Probable Cause for Vehicle Searches, Minnesota Court Affirms
-
Business1 year agoNew Mexico cannabis operator fined, loses license for alleged BioTrack fraud
-
Business1 year agoAlabama to make another attempt Dec. 1 to award medical cannabis licenses
-
Business1 year agoWashington State Pays Out $9.4 Million in Refunds Relating to Drug Convictions
-
Business1 year agoMarijuana companies suing US attorney general in federal prohibition challenge
-
Business1 year agoLegal Marijuana Handed A Nothing Burger From NY State
-
Business1 year agoCan Cannabis Help Seasonal Depression
-
Blogs1 year agoCannabis Art Is Flourishing On Etsy